CRISPR Therapeutics (CRSP) PT Lowered to $120 at Truist Securities
Tweet Send to a Friend
(Updated - February 7, 2024 2:28 PM EST)
Truist Securities analyst Joon Lee lowered the price target on CRISPR ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Joon Lee lowered the price target on CRISPR ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
